RE:All things considered.Theralase just needs a distribution partner.
jmm1228 wrote: Theralase is likely on the threshold of a major triumph in the treatment of cancer and some other diseases.
It has none of the characteristics inherent of the major successful pharmas. Less than 20 employees whosse main responsibility is overseeing trial patients and preparing reports.
With expected FDA approvals in the near term what is in place to serve the expected demand and associated service issues? Nothing.
Most seasoned executives, IMO, assessing the situation, would conclude that the way forward calls for a transfer of the TLT assets to an entity with all the management structure in place necessary to secure the potential opportunities expeditiously.
RDW is too smart not to know this.